IVIM Health vs BreezeMeds: pricing, reviews, and formulation differences

IVIM Health vs BreezeMeds quickly: IVIM emphasizes dual 4.9-star ratings, a no-obligation free consultation and a GIFT75 free month membership code, while BreezeMeds lists multiple starting prices with injectable and oral GLP-1 options and discreet shipping. Early verdict: IVIM stands out for its verified third-party ratings and an explicit free consult offer; BreezeMeds is more variable on pricing and product presentation.

IVIM Health vs BreezeMeds: 5 key differences buyers should know

This comparison focuses on the most distinctive differences supported by the source: third-party ratings and trust signals, pricing transparency and starting rates, product formats and compounding status, clinical claims and evidence, and membership or consult offers.

1. Third-party ratings and trust signals

IVIM Health: The source reports a 4.9-star rating on both Google and Trustpilot, described as an unusually strong dual verification across major review platforms. BreezeMeds: No dual third-party ratings were captured in the source. If independent review scores are a priority, the evidence shows IVIM making that claim prominently.

2. Pricing transparency and starting rates

IVIM Health: The source lists prices such as $75/mo for semaglutide compounded, $133/mo for tirzepatide compounded, plus a $74.99/mo program fee, and an FAQ stating first month starts at $99 and ongoing $174/month with the GIFT75 free-month code available for new patients. BreezeMeds: The source lists multiple starting figures including semaglutide injection from $199/mo, tirzepatide injection from $299, and oral options from $399, with an additional $169 figure that is not clearly tied to a specific product. The BreezeMeds presentation suggests varied starting points and some price items were not clearly associated with specific products.

3. Product formats and compounding status

IVIM Health: The source repeatedly identifies IVIM medications as compounded formulations and emphasizes that compounded drugs are not FDA-approved and have not undergone FDA review for safety, efficacy, or quality. IVIM notes both semaglutide and tirzepatide are offered as compounded products prescribed after consultation. BreezeMeds: The source lists injectable and oral semaglutide and tirzepatide options and flags that medication-specific approval status must be confirmed, and that compounded medications, when offered, are not FDA-approved. Both providers require clinician review to determine medical appropriateness, and the sources preserve that FDA approval status must be confirmed.

4. Clinical claims and evidence

IVIM Health: The source attributes to IVIM a proprietary GLP-1 ID protocol that the company says can accelerate weight loss outcomes by up to 40% and cites IVIM-published observational studies and retrospective analyses. The source preserves the qualifier that these are not randomized controlled head-to-head trials and that the 40% figure is an IVIM protocol claim, not an independent clinical trial result. BreezeMeds: The source did not capture comparable clinical outcome claims or independent studies; it focuses on availability of drug formats and discreet shipping. If clinical outcome claims and internal studies matter, IVIM explicitly presents those claims with qualifying language in the source.

5. Membership, consults and enrollment signals

IVIM Health: The source documents a no-obligation free consultation valued at $75 for new patients and a GIFT75 free month membership code. It also notes membership program fees and ongoing pricing details in captured FAQs. BreezeMeds: The source highlights online intake, personalized plans and discreet home delivery but the source does not show an explicit free consult or a free-month code; pricing and fee commitments were not fully visible. The BreezeMeds entry recommends confirming eligibility, total cost, renewal terms and state availability before enrollment.

Side-by-side at a glance

How to decide: practical takeaways

If independent third-party reviews and an explicit free consult offer matter, the source shows IVIM Health highlighting dual 4.9-star ratings and a no-obligation $75-value consultation plus a GIFT75 free month membership code. If you need a broader set of format options and are prepared to clarify exact product pricing and state availability, BreezeMeds lists injectable and oral options with multiple starting prices and emphasizes discreet shipping, but the source shows some pricing items were not clearly tied to specific products.

Choose IVIM Health if…

• You value verified third-party satisfaction evidence and a no-obligation free consultation as shown in the source.
• You prefer a clinician-guided, proprietary GLP-1 ID protocol and the option to use the GIFT75 free month membership code.
• You accept compounded medication models and the regulatory qualifiers the source preserves.

Choose BreezeMeds if…

• You want injectable and oral format listings up front and are prepared to confirm exact pricing, renewal terms and state availability with BreezeMeds as recommended in the source.

In summary, IVIM Health vs BreezeMeds narrows to trust signals and consult offers versus broader format listings and variable starting prices. Use the provider details above to match the source evidence to your priorities.